Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
39,890
Total Claims
$9.7M
Drug Cost
30,373
Beneficiaries
$321
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-70%
Cost per patient vs peers
$321 vs $1,068 avg
+925%
Brand preference vs peers
92.2% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
Brand: 36,648 claims · $9.6M
Generic: 3,091 claims · $96K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Varicella-Zoster Ge/As01b/Pf | 17,796 | $3.8M |
| Rsv Vacc, Pref A And Pref B/Pf | 8,828 | $2.9M |
| Rsvpref3 Antigen/As01e/Pf | 7,105 | $2.3M |
| Diphth,pertuss(Acell),tet Vac | 2,062 | $140K |
| Sitagliptin Phosphate | 53 | $70K |
| Icosapent Ethyl | 128 | $64K |
| Empagliflozin | 49 | $55K |
| Dulaglutide | 21 | $37K |
| Apixaban | 31 | $28K |
| Abaloparatide | 11 | $27K |
| Tirzepatide | 13 | $23K |
| Insulin Degludec | 19 | $22K |
| Icosapent Ethyl | 60 | $20K |
| Lipase/Protease/Amylase | 11 | $17K |
| Diclofenac Epolamine | 28 | $14K |
Prescribing Profile
Patient Profile
75
Avg Age
59%
Female
0.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data